{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T02:48:46Z","timestamp":1777517326283,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.cbi.2015.11.018","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T05:30:18Z","timestamp":1448602218000},"page":"10-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet"],"prefix":"10.1016","volume":"243","author":[{"given":"Danielle","family":"Camer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinghua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Szabo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi H.L.","family":"Dinh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2015.11.018_bib1","first-page":"e29","article-title":"Heart disease and stroke statistics\u20132015 update: a report from the American Heart Association","volume":"131","author":"Mozaffarian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cbi.2015.11.018_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib3","doi-asserted-by":"crossref","first-page":"210","DOI":"10.5527\/wjn.v3.i4.210","article-title":"Metabolic syndrome and chronic kidney disease: current status and future directions","volume":"3","author":"Prasad","year":"2014","journal-title":"World J. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib4","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1146\/annurev.pharmtox.41.1.851","article-title":"Endothelin system: the double-edged sword in health and disease","volume":"41","author":"Kedzierski","year":"2001","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2015.11.018_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejphar.2014.05.046","article-title":"Endothelin ETA receptor antagonism in cardiovascular disease","volume":"737","author":"Nasser","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2015.11.018_bib6","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","article-title":"The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension","volume":"338","author":"Krum","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib7","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0895-7061(02)02933-3","article-title":"Darusentan: an effective endothelinA receptor antagonist for treatment of hypertension","volume":"15","author":"Nakov","year":"2002","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cbi.2015.11.018_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.mnh.0000186852.15889.1a","article-title":"The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure","volume":"15","author":"Kohan","year":"2006","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"issue":"Suppl.\u00a04","key":"10.1016\/j.cbi.2015.11.018_bib9","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1038\/sj.ijo.0802858","article-title":"Ectopic fat storage in heart, blood vessels and kidneys in the pathogenesis of cardiovascular diseases","volume":"28","author":"Montani","year":"2004","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"10.1016\/j.cbi.2015.11.018_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-014-0165-0","article-title":"Involvement of peroxisome proliferator-activated receptors in cardiac and vascular remodeling in a novel mini pig model of insulin resistance and atherosclerosis induced by consumption of a high-fat\/cholesterol diet","volume":"14","author":"Yongming","year":"2015","journal-title":"Cardiovasc Diabetol."},{"key":"10.1016\/j.cbi.2015.11.018_bib11","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1042\/CS20090395","article-title":"Obesity is the major contributor to vascular dysfunction and inflammation in high-fat diet hypertensive rats","volume":"118","author":"Elmarakby","year":"2010","journal-title":"Clin. Sci. Lond."},{"key":"10.1016\/j.cbi.2015.11.018_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/ncb3120","article-title":"Ppm1b negatively regulates necroptosis through dephosphorylating Rip3","volume":"17","author":"Chen","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cbi.2015.11.018_bib13","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/mnfr.201300861","article-title":"The molecular mechanisms underpinning the therapeutic properties of oleanolic acid, its isomer and derivatives for type 2 diabetes and associated complications","volume":"58","author":"Camer","year":"2014","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.cbi.2015.11.018_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","article-title":"Bardoxolone methyl and kidney function in CKD with type 2 diabetes","volume":"365","author":"Pergola","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1159\/000327599","article-title":"Effect of bardoxolone methyl on kidney function in patients with T2D and Stage 3b-4 CKD","volume":"33","author":"Pergola","year":"2011","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib16","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1159\/000346948","article-title":"Rationale and trial design of Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: the Occurrence of Renal Events (BEACON)","volume":"37","author":"de Zeeuw","year":"2013","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib17","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1172\/JCI69672","article-title":"Synthetic triterpenoid induces 15-PGDH expression and suppresses inflammation-driven colon carcinogenesis","volume":"124","author":"Choi","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.cbi.2015.11.018_bib18","doi-asserted-by":"crossref","first-page":"40581","DOI":"10.1074\/jbc.M110.176545","article-title":"The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic-acid methyl ester has potent anti-diabetic effects in diet-induced diabetic mice and Lepr(db\/db) mice","volume":"285","author":"Saha","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.cbi.2015.11.018_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2015.01.025","article-title":"Bardoxolone methyl prevents fat deposition and inflammation in the visceral fat of mice fed a high-fat diet","volume":"229","author":"Dinh","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2015.11.018_bib20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pnpbp.2015.01.004","article-title":"Bardoxolone methyl prevents high-fat diet-induced alterations in prefrontal cortex signalling molecules involved in recognition memory","volume":"59","author":"Camer","year":"2015","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.cbi.2015.11.018_bib21","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.mce.2015.05.018","article-title":"Bardoxolone methyl prevents insulin resistance and the development of hepatic steatosis in mice fed a high-fat diet","volume":"412","author":"Camer","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.cbi.2015.11.018_bib22","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1056\/NEJMoa1306033","article-title":"Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease","volume":"369","author":"de Zeeuw","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000362906","article-title":"Mechanisms Contributing to Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stage 4 Chronic Kidney Disease Treated with Bardoxolone Methyl","volume":"39","author":"Chin","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib24","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1159\/000368563","article-title":"The endothelin pathway: a protective or detrimental target of bardoxolone methyl on cardiac function in patients with advanced chronic kidney disease?","volume":"40","author":"Camer","year":"2014","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.tox.2014.01.008","article-title":"Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway","volume":"318","author":"Wu","year":"2014","journal-title":"Toxicology"},{"key":"10.1016\/j.cbi.2015.11.018_bib26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1177\/0748730407302625","article-title":"Attenuating effect of clock mutation on triglyceride contents in the ICR mouse liver under a high-fat diet","volume":"22","author":"Kudo","year":"2007","journal-title":"J.\u00a0Biol. Rhythms"},{"key":"10.1016\/j.cbi.2015.11.018_bib27","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nprot.2013.055","article-title":"Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease","volume":"8","author":"Mehlem","year":"2013","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.cbi.2015.11.018_bib28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1046\/j.1523-1755.1999.00728.x","article-title":"The cyclin kinase inhibitor p21WAF1\/CIP1 is required for glomerular hypertrophy in experimental diabetic nephropathy","volume":"56","author":"Al-Douahji","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.cbi.2015.11.018_bib29","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1681\/ASN.V1261211","article-title":"Functional and structural changes in the kidney in the early stages of obesity","volume":"12","author":"Henegar","year":"2001","journal-title":"J.\u00a0Am. Soc. Nephrol."},{"key":"10.1016\/j.cbi.2015.11.018_bib30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jnutbio.2014.12.011","article-title":"Palmitic acid induces central leptin resistance and impairs hepatic glucose and lipid metabolism in male mice","volume":"5","author":"Cheng","year":"2015","journal-title":"J.\u00a0Nutr. Biochem."},{"key":"10.1016\/j.cbi.2015.11.018_bib31","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s11906-014-0529-6","article-title":"The Western diet and chronic kidney disease","volume":"17","author":"Hariharan","year":"2015","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.cbi.2015.11.018_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/apha.12308","article-title":"Fatty acids and cardiac disease: fuel carrying a message","volume":"211","author":"van Bilsen","year":"2014","journal-title":"Acta Physiol. Oxf."},{"key":"10.1016\/j.cbi.2015.11.018_bib33","doi-asserted-by":"crossref","first-page":"F118","DOI":"10.1152\/ajprenal.00110.2008","article-title":"Structural and functional changes in the kidneys of high-fat diet-induced obese mice","volume":"296","author":"Deji","year":"2009","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cbi.2015.11.018_bib34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/1471-2261-14-123","article-title":"Chronic high-fat diet-induced obesity decreased survival and increased hypertrophy of rats with experimental eccentric hypertrophy from chronic aortic regurgitation","volume":"14","author":"Dhahri","year":"2014","journal-title":"BMC Cardiovasc. Disord."},{"key":"10.1016\/j.cbi.2015.11.018_bib35","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jacc.2010.10.042","article-title":"Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort","volume":"57","author":"Russo","year":"2011","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2015.11.018_bib36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1476-5381.2011.01472.x","article-title":"Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction","volume":"165","author":"Barton","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2015.11.018_bib37","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib38","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1096\/fasebj.5.15.1835945","article-title":"Regulation of cardiac gene expression during myocardial growth and hypertrophy: molecular studies of an adaptive physiologic response","volume":"5","author":"Chien","year":"1991","journal-title":"FASEB J."},{"key":"10.1016\/j.cbi.2015.11.018_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/cvr\/cvq401","article-title":"Suppression of endothelin-1-induced cardiac myocyte hypertrophy by PPAR agonists: role of diacylglycerol kinase zeta","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.cbi.2015.11.018_bib40","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1097\/01.fjc.0000190489.85058.7e","article-title":"Pomegranate flower extract diminishes cardiac fibrosis in Zucker diabetic fatty rats: modulation of cardiac endothelin-1 and nuclear factor-kappaB pathways","volume":"46","author":"Huang","year":"2005","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"key":"10.1016\/j.cbi.2015.11.018_bib41","first-page":"509","article-title":"Increased gene expression of the cardiac endothelin system in obese mice","volume":"7","author":"Catar","year":"2015","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.cbi.2015.11.018_bib42","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0735-1097(97)00296-9","article-title":"Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure","volume":"30","author":"Wada","year":"1997","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.cbi.2015.11.018_bib43","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.HYP.22.3.292","article-title":"Obesity-induced hypertension. Renal function and systemic hemodynamics","volume":"22","author":"Hall","year":"1993","journal-title":"Hypertension"},{"key":"10.1016\/j.cbi.2015.11.018_bib44","doi-asserted-by":"crossref","first-page":"440","DOI":"10.7326\/0003-4819-81-4-440","article-title":"The nephrotic syndrome: a complication of massive obesity","volume":"81","author":"Weisinger","year":"1974","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.cbi.2015.11.018_bib45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.lfs.2014.09.009","article-title":"Aging and endothelin: determinants of disease","volume":"118","author":"Barton","year":"2014","journal-title":"Life Sci."},{"key":"10.1016\/j.cbi.2015.11.018_bib46","doi-asserted-by":"crossref","first-page":"227A","DOI":"10.1016\/S0895-7061(01)01897-0","article-title":"P-590: Obesity regulates renal endothelin and endothelin ETA receptor expression in\u00a0vivo. Differential effects of chronic ETA receptor blockade","volume":"14","author":"Zhang","year":"2001","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.cbi.2015.11.018_bib47","doi-asserted-by":"crossref","first-page":"F1180","DOI":"10.1152\/ajprenal.00353.2010","article-title":"Bardoxolone methyl (BARD) ameliorates ischemic AKI and increases expression of protective genes Nrf2, PPARgamma, and HO-1","volume":"300","author":"Wu","year":"2011","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cbi.2015.11.018_bib48","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1038\/ki.2012.439","article-title":"Targeting the transcription factor Nrf2 to ameliorate oxidative stress and inflammation in chronic kidney disease","volume":"83","author":"Ruiz","year":"2013","journal-title":"Kidney Int."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715301204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279715301204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:45:18Z","timestamp":1762112718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279715301204"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":48,"alternative-id":["S0009279715301204"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2015.11.018","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bardoxolone methyl prevents the development and progression of cardiac and renal pathophysiologies in mice fed a high-fat diet","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2015.11.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}